Ginkgolide B

Drug Profile

Ginkgolide B

Alternative Names: BN 52021

Latest Information Update: 21 Aug 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ipsen
  • Developer Ipsen; Nonindustrial sources
  • Class Lactones; Small molecules
  • Mechanism of Action Immunosuppressants; Platelet activating factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arrhythmias; Arterial thrombosis; Asthma; Cancer; Gram-negative infections; Ischaemic heart disorders; Lung transplant rejection; Multiple sclerosis; Peptic ulcer; Renal transplant rejection; Septic shock; Xenotransplant rejection

Most Recent Events

  • 17 Nov 2002 Discontinued - Preclinical for Cancer in France (unspecified route)
  • 17 Nov 2002 Discontinued for Cancer in Hungary (unspecified route)
  • 14 Nov 2002 Discontinued - phase III for Septic shock in Europe (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top